Pharmaids Pharmaceuticals share news and announcements
BSE: 524572Pharmaceuticals & BiotechnologySmall Cap
Last close ₹28.92up ₹0.63 (2.23%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹28.29.
52-week range of traded prices to 23 Oct 2026
₹25.60Low, 1 Jun 2026₹53.90High, 9 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹102 Cr2,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 1 Jun 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −8.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹6.70 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −21.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −15.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 1 Jun 2026
- 0.44
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,482
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Pharmaids Pharmaceuticals quarterly results
Aug12Wed
The board met on 12 Aug 2026 to consider quarterly results
Notice filed 6 Aug 2026
Pharmaids Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Pharmaids Pharmaceuticals financials, year by year
Annual reports29
- Annual report, year to Mar 2026 (opens in a new tab)18 Aug 2026
- Annual report, year to Mar 2025 (opens in a new tab)29 Aug 2025
- Annual report, year to Mar 2024 (opens in a new tab)3 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)31 Aug 2023
- Annual report, year to Mar 2022 (opens in a new tab)23 Jul 2022
24 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)30 Aug 2021
- Annual report, year to Mar 2020 (opens in a new tab)21 Aug 2020
- Annual report, year to Mar 2019 (opens in a new tab)6 Sep 2019
- Annual report, year to Mar 2018 (opens in a new tab)3 Oct 2018
- Annual report, year to Mar 2017 (opens in a new tab)29 Sep 2017
- Annual report, year to Mar 2016 (opens in a new tab)4 Oct 2016
- Annual report, year to Mar 2015 (opens in a new tab)5 Sep 2015
- Annual report, year to Mar 2014 (opens in a new tab)18 Jul 2014
- Annual report, year to Mar 2013 (opens in a new tab)4 Sep 2013
- Annual report, year to Mar 2012 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2011 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1998 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1997 (opens in a new tab)Filing day not known
Pharmaids Pharmaceuticals share news and announcements
617 announcements, routine notices left out, newest first. Page 1 of 13.
Sep 2026
16 Sep · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Aug 2026
18 Aug · Meeting
12 Aug · Results
6 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jun 2026
13 Jun · Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Providing Corporate Guarantee To Subsidiary
May 2026
22 May · Board meeting
Meeting on 29 May 2026: audited results
Mar 2026
Feb 2026
24 Feb · Intimation Of Receipt Of Accreditation By The American Association For Laboratory Accreditation (A2LA) For Testing Of Medical Devices In Biological Field.
9 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly results
Jan 2026
5 Jan · Outcome Of The Circular Resolution Dated 05Th January 2026.
Dec 2025
10 Dec · Management
Nov 2025
29 Nov · Meeting
28 Nov · Outcome Of The Circular Resolution Dated 28Th November 2025.
6 Nov · Board meeting
Meeting on 11 Nov 2025: quarterly results
Sep 2025
6 Sep · Announcement Under Regulation 30 - Intimation Of Registration Of Sale Deed.
Aug 2025
29 Aug · Announcement under Regulation 30 (LODR)-Open Offer - Updates
29 Aug · Post Offer Advertisement
21 Aug · Management
21 Aug · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 1 Jul 2026Board or managers changeddown 5.93%−6.4 pts vs Nifty 500market median 0.0% · five sessions −11.0% (−12.6 pts vs Nifty 500) · volume 2.1× usual · The announcement (opens in a new tab)
- 29 Jun 2026Board or managers changedup 0.82%+1.3 pts vs Nifty 500market median 0.0% · five sessions −7.7% (−8.5 pts vs Nifty 500) · volume 1.5× usual · The announcement (opens in a new tab)
- 6 Jan 2026Board or managers changeddown 4.10%−3.9 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−0.3 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 2 Jan 2026Board or managers changeddown 3.42%−4.2 pts vs Nifty 500market median 0.0% · five sessions +0.2% (+1.1 pts vs Nifty 500) · volume 1.1× usual · The announcement (opens in a new tab)
- 11 Dec 2025Board or managers changedup 0.28%−0.3 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−4.1 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 1 Dec 2025Board or managers changeddown 4.13%−4.1 pts vs Nifty 500market median 0.0% · five sessions +9.8% (+10.2 pts vs Nifty 500) · volume 1.7× usual · The announcement (opens in a new tab)
- 25 Sep 2025Board or managers changedup 2.02%+2.7 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−1.0 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 8 Aug 2025Board or managers changeddown 0.30%+0.8 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−2.0 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 7 Jul 2025Board or managers changeddown 1.44%−1.4 pts vs Nifty 500market median 0.0% · five sessions +10.4% (+11.5 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 27 Mar 2025Board or managers changeddown 0.96%−1.6 pts vs Nifty 500market median 0.0% · five sessions +3.2% (+3.4 pts vs Nifty 500) · volume 1.0× usual · The announcement (opens in a new tab)
16 earlier announcements
- 13 Feb 2025Board or managers changedup 0.45%+0.5 pts vs Nifty 500market median 0.0% · five sessions −8.4% (−7.6 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 6 Aug 2024Board or managers changeddown 1.20%−0.8 pts vs Nifty 500market median 0.0% · five sessions −3.1% (−4.8 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 29 May 2024Board or managers changeddown 2.14%−1.5 pts vs Nifty 500market median 0.0% · five sessions −7.5% (−2.6 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 27 May 2024Board or managers changedup 0.05%0.0 pts vs Nifty 500market median 0.0% · five sessions −9.9% (−8.1 pts vs Nifty 500) · volume 1.2× usual · The announcement (opens in a new tab)
- 24 May 2024Board or managers changeddown 1.99%−2.0 pts vs Nifty 500market median 0.0% · five sessions −11.1% (−9.0 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 12 Feb 2024Board or managers changeddown 4.99%−3.6 pts vs Nifty 500market median 0.0% · five sessions −5.3% (−6.3 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 8 Jan 2024Board or managers changedup 4.99%+5.9 pts vs Nifty 500market median 0.0% · five sessions +15.4% (+14.7 pts vs Nifty 500) · volume 2.8× usual · The announcement (opens in a new tab)
- 30 Aug 2023Board or managers changeddown 4.85%−5.1 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−5.1 pts vs Nifty 500) · volume 1.9× usual · The announcement (opens in a new tab)
- 4 Aug 2023Board or managers changeddown 1.99%−2.7 pts vs Nifty 500market median 0.0% · five sessions −9.5% (−10.5 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 23 Jan 2023Board or managers changedup 4.98%+4.3 pts vs Nifty 500market median 0.0% · five sessions +13.6% (+15.8 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 14 Oct 2022Board or managers changedup 1.41%+0.8 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−1.9 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 4 Aug 2022Board or managers changedup 1.89%+1.8 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−3.4 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 11 Jul 2022Board or managers changedup 2.71%+2.3 pts vs Nifty 500market median 0.0% · five sessions +1.3% (+1.6 pts vs Nifty 500) · volume 0.9× usual · The announcement (opens in a new tab)
- 23 Nov 2020Board or managers changedup 1.99%+1.3 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+8.8 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 31 Jul 2020Board or managers changed–market median 0.0% · five sessions −22.1% (−28.1 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
- 10 Dec 2012Board or managers changeddown 4.97%−5.1 pts vs Nifty 500market median 0.0% · five sessions −21.0% (−20.4 pts vs Nifty 500) · volume 0.0× usual
Figures filed again
The latest 30. Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Cash at the end of the period | At Mar 2026 | Consolidated | 0.13 | 0.13 | +0.1% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Cash from financing | Year to Mar 2026 | Consolidated | −19.97 | −19.97 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Cash from financing | Year to date to Mar 2026 | Consolidated | −19.97 | −19.97 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Other cash from financing | Year to Mar 2026 | Consolidated | −0.81 | −0.81 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Other cash from financing | Year to date to Mar 2026 | Consolidated | −0.81 | −0.81 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Net change in cash, before currency effects | Year to Mar 2026 | Consolidated | −0.69 | −0.69 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Net change in cash | Year to Mar 2026 | Consolidated | −0.69 | −0.69 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Net change in cash, before currency effects | Year to date to Mar 2026 | Consolidated | −0.69 | −0.69 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Net change in cash | Year to date to Mar 2026 | Consolidated | −0.69 | −0.69 | 0.0% | 30 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |
| Cash generated before tax | Year to date to Mar 2026 | Standalone | −2.27 | −3.53 | −55.4% | 29 May 2026 (opens in a new tab) | 1 Jun 2026 (opens in a new tab) |